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Summary. Administration of tamoxifen orally (3 mg/kg/day) during the post-ovulatory
period from Days 16 to 20 or from Days 18 to 30 of female bonnet monkeys mated
between Days 9 and 14 of the cycle resulted in inhibition of pregnancy establishment in
90\p=n-\100%of monkeys tested. The pregnancy establishment in control female monkeys
after exposure to the male during one ovulatory cycle was 66%. The effect of tamoxifen
was not due to interference with luteal function because there was no reduction in
serum progesterone concentrations after drug treatment. Exogenously administered
progesterone could not reverse the inhibitory effect of tamoxifen on pregnancy estab-
lishment. The effect of tamoxifen was dose-dependent. We suggest that tamoxifen
could be developed as an effective post-ovulatory contraceptive for regulation of
female fertility.
Introduction
Progesterone plays an indispensable role in preparing the uterine endometrium for implantation
and maintenance of pregnancy in many mammals, including primates. The idea that oestrogen is
probably not required for implantation and maintenance of early pregnancy in primates (including
the human) stems from the observation that rhesus monkeys ovariectomized within 2-6 days of
ovulation or with corpus luteum excision on Day 5 or 6 after ovulation continue pregnancy if
treated with progesterone alone (Meyer et al, 1969). Bosu & Johansson (1975), however, observed
that out of 6 ovariectomized monkeys, progesterone treatment maintained pregnancy in only one
animal. Several antioestrogens effective in inhibiting implantation in the rat have also been shown
to block pregnancy in the rhesus monkey (Morris et al, 1967). Most of these compounds have
pronounced oestrogenic activity as well as antioestrogenic activity. Moreover, these compounds
were given immediately after mating and so an effect on ovum/blastocyst survival or maturation
cannot be discounted.
Implantation occurs between Days 7 and 9 after ovulation in the macaque (Heuser & Streeter,
1941) and about Days 6-7 in the human (O'Rahilly, 1973). Patterns of circulating oestradiol and
total oestrogen during the perimplantation period have been described, for the marmoset (Hearn et
al, 1978), rhesus monkey (Anand Kumar et al, 1980), bonnet monkey (Murty et al, 1980), chim¬
panzee (Hendrickx & Enders, 1980) and the human (Thomas et al, 1973). Generally the peri-
implantation concentration of serum oestradiol is higher in the fertile than in the infertile cycle.
Although the role of this oestrogen remains unclear, the high concentrations of oestradiol and
those of progesterone are used as one of the markers of pregnancy establishment in the non-human
primate (Atkinson et al, 1975).
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We have investigated whether oestrogen is required for the establishment of pregnancy in the
bonnet monkey by using a relatively pure antioestrogen, tamoxifen, to deprive the uterus of oestro¬
genic support at the appropriate time. A preliminary report on the usefulness of tamoxifen in
studying oestrogen requirement in early pregnancy in primates has been made (Ravindranath &
Moudgal, 1986).
Materials and Methods
Animals and husbandry. The experiments described herein required the use of a standardized primate breeding colony
whose reproductive endocrinology was well established. The south Indian bonnet monkeys (Macaca radiata) were
maintained under standard husbandry conditions as described earlier (Prahalada et a!, 1975).
General methodology. All monkeys used in the present study were healthy adult females of recorded proven
fertility. The ovulatory nature of the menstrual cycle was established by assaying for oestradiol-17ß and progesterone
in serum samples obtained from monkeys on Days 7-10 and 14-18 of the cycle respectively. Unless otherwise stated
female monkeys which showed high serum oestrogen values between Days 7 and 9 were placed with proven fertile
males between Days 9 and 14 of cycle and only those monkeys that showed an increasing trend in progesterone values
starting from Day 14 of the cycle were chosen and randomly allotted to the control or experimental group.
Determining the establishment ofpregnancy. Based on the observation of Prahalada et a! (1975) that there is a
significant increment in the serum progesterone and oestradiol concentrations from Day 25 onwards in bonnet
monkeys which have undergone a fertile mating compared to those that have experienced an infertile mating (or that
exhibited by unmated cyclic monkeys), the concentrations of these two hormones were used as an early index of
pregnancy. Detection of increasing concentrations of chorionic gonadotrophin (CG) from Day 28 onwards(jagannadha Rao et a!, 1984) and rectal palpation, if necessary, around Day 45 provided confirmatory evidence for
pregnancy establishment.
Hormones and antioestrogen. Tamoxifen, an antioestrogen (Z)-2(4-(l,2-diphenylbut-l-enyl)phenoxy)-JV,N-
dimethyl ethanamine, was a gift of ICI, U.K., made available by Dr  . J. A. Furr through the WHO, Geneva.
Progesterone and medroxyprogesterone acetate used here were products of Steraloids Inc., New Haven, CT, U.S.A.
and Upjohn Company, Puurs, Belgium, respectively.
Hormone assays. Blood samples were taken from unanaesthetized monkeys by means of vaccutainer tubes. The
sera were separated and stored at
—
20°C before assay. Radioimmunoassay procedures used for determining oestro¬
gen and progesterone were based on methods standardized and in regular use in this laboratory and described earlier
by Prahalada et a! (1975). The serum samples to which an internal standard of tritiated steroid had been added were
extracted with diethyl ether. The extracted steroid was measured in duplicate in a liquid-phase system comprising
tritiated steroid antigen and antiserum to steroid-BSA conjugate. Dextran-coated charcoal was used to adsorb
unbound steroid. The oestradiol assay had an intra-assay coefficient of variation of 12-5% and a sensitivity of
001 ng/ml. The oestradiol antiserum showed a cross-reaction of 10% with oestrone and <1% with oestriol and
testosterone.
The progesterone assay had an intra-assay coefficient of variation of 8% and a sensitivity of 001 ng/ml.
The progesterone antiserum showed a cross-reaction of 3% with 17a-hydroxyprogesterone and 5% with
20a-dihydroprogesterone.
Radioimmunoassay used for determining chorionic gonadotrophin in fertile cycles of bonnet monkeys was
according to the method described by Jagannadha Rao et a! (1984). This consisted of incubating serum samples and
hCG standards (range from 100 pg to 100 ng) and 125I-labelled hCG with a rabbit antiserum to ovine LH ß-subunit
for 12 h at room temperature. Bound and free hormone were separated by adding goat anti-rabbit  -globulin serum
and the radioactivity precipitated was measured in an autogamma spectrometer. The monkey CG in serum samples
was expressed as hCG equivalent read from hCG standards used in the assay. The assay had an intra-assay coefficient
of variation of 10-8% and a sensitivity of 5 ng/ml. This assay is specific to CG and does not exhibit cross-reactivity
with monkey pituitary extract or serum from castrated monkeys (Jagannadha Rao et a!, 1984).
Treatment with tamoxifen. Tamoxifen was administered orally to all animals in the treatment group at 10:00 h; the
dose, duration and groups given tamoxifen are described with the relevant experiments. The controls received no
treatment. The female monkeys used here weighed ~ 5 kg each and all doses administered unless otherwise specified
refer to daily doses per monkey computed for 5 kg body weight.
Results
Effect of tamoxifen on lutealfunction and cycle length in cyclic females
Administration of tamoxifen (15 mg/day) to a group of 4 cyclic but unmated monkeys from
Days 18 to 30 of the cycle resulted in an extension of the luteal phase of the cycle and hence of the
Table 1. Effect of tamoxifen feeding on cycle length of female bonnet monkeys
Group
Treatment
duration
Daily dose(mg)
No. of
females
Length of cycle(days)
Length of
luteal phaset(days)
I
II
III
IV
Control
Days 18-30
Days 18-30
Days 16-18
150
2-5
150
28-0 ± 0-56
58-7 + 3-8*
27-2 ± 1-4
28-2
17-2 ± 0-5
390 + 5-4*
18-7 ± 1-4
18-5
tNo. of days elapsed between the day of oestradiol surge and end of the cycle.
 Significantly different from controls,  < 001 (Student's t test).
Values are mean + s.e.m.
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Fig. 1. Oestradiol (·—·) and progesterone (·-·) concentrations (mean + s.d.) during
the luteal phase of the menstrual cycle in mated female bonnet monkeys fed with tamoxifen.
Group I, controls (N = 6); Group II, tamoxifen, 15 mg daily from Days 18 to 30 (N = 4);
Group III, tamoxifen, 2-5 mg daily from Days 18 to 30 (N = 5); Group IV, tamoxifen, 15 mg
daily from Days 16 to 18 (N = 2).
cycle length (Table 1). Tamoxifen appeared to promote luteal function because progesterone con¬
centrations remained high, even up to the 35th day after the last menstrual flow, instead of becom¬
ing low by Day 26-28, as in the normal cycle (Fig. 1, Group II); tamoxifen had no effect on serum
oestrogen concentrations (Fig. 1, Group II). Reducing the dose of tamoxifen to 2-5 mg/day on
Days 18-30 or to 15 mg/day on Days 16-18 only did not influence cycle length or luteal function(Table 1). Prolongation of luteal function as indicated by high progesterone values beyond Day 28
of the cycle was not seen when tamoxifen dosage was reduced to 2-5 mg/day or the duration of
exposure to tamoxifen was reduced from 13 days to 5 days (compare Groups III & IV with I & II in
Fig. 1). The serum oestrogen values after low-dose tamoxifen treatment (2-5 mg daily) showed an
increase compared to those seen after the 15 mg dose (compare Group III with Groups II & IV,
Fig. 1), but the reasons for this are not apparent at present.
Fertility status of the primate colony
Since it was planned to study the effect of tamoxifen on the establishment of pregnancy in
proven fertile monkeys, it was essential to determine the fertility status of the female monkeys of
the colony. Considering the data from mating of monkeys showing an ovulatory cycle only for
analysis, the colony showed an overall pregnancy index of 82% and this was achieved by mating
during 3 successive ovulatory cycles. However, 60% of the ovulatory cycling monkeys that mated
became pregnant in the first cycle. The data obtained with the control group of this investigation
are consistent with that recorded for the past 5 years for the colony (Table 2). The present series of
experiments were carried out during the most fertile period of the year extending from August to
March of each year. Data pertaining to conception obtained from only one ovulatory cycle have
been included in the current study.
Table 2. Fertility status of female bonnet monkeys held in the colony over a
5-year period
No. becoming pregnant after exposure:
Year No. Total %(July-March) mated 1st 2nd 3rd pregnancy
1981-82 17 10(58-8) 4(23-5) 82-3
1982-83 45 27(60) 7(15-5) 3(6-6) 82-1
1983-84 28 18(64-3) 4(14-3) 1(3-5) 82-1
1984-85 35 20(57-1) 8(22-8) 1(2-8) 82-7
1985-86 27 16(59-2) 5(18-5) 81-4
Mean + s.d.
% pregnancies 59 + 2-9 18-9 + 4-2 4-3 + 2-0 82-1+0-5
Figures in parentheses indicate percentage pregnancies.
Effect of tamoxifen on establishment ofpregnancy
Female monkeys with a proven fertility record were mated individually with proven fertile
males between Days 9 and 14 of the cycle. Monkeys that exhibited ovulatory cycles (based on
oestrogen and progesterone profiles) were allocated to four groups: monkeys in Group I served as
controls and received no treatment, those in Group II received tamoxifen (15 mg/day) from Days
18 to 30 of the cycle, and those in Groups III and IV received 15 mg tamoxifen/day as in Group II
and also s.c. injections of 10 mg medroxyprogesterone acetate (MPA) or progesterone respectively.
Administration of tamoxifen led to prevention of establishment of pregnancy in 9 out of
10 monkeys (Table 3, Group II). In 5 monkeys, the cycle ended on Day 23 and CG could not
be detected. Of the remaining 5 monkeys, which were CG-positive on Day 28, 3 exhibited
menstruation on Day 29, 1 on Day 56 and one continued pregnancy to term.
Simultaneous administration of MPA or progesterone was not able to override the effect of
tamoxifen to any marked extent; only 3 out of 16 monkeys (Table 3, Groups III & IV) became
pregnant. Of 5 monkeys that were treated with MPA (Group III), 4 were CG-positive between
Days 28 and 33 and 3 of these showed vaginal bleeding between Days 66 and 77, while one monkey
continued pregnancy to term. The 5th monkey, although it was not CG-positive, showed bleeding
on the 74th day from the day of last menstrual flow. Considering that MPA has a long half-life and
Table 3. Demonstration of specificity of tamoxifen (TMX) effect on conferring
protection against pregnancy
No. pregnant
Treatment
-
%
Group (duration days) No. mated No. expected* No. recorded protection
I Control 6 4 4 0
II TMX (18-30) 10 6 1 84
III TMX (18-30) 5 3 1 67
+
MPA
IV TMX (18-30) 11 6 2 72
+
progesterone
Except for controls, which did not receive any treatment, all animals received 15 mg tamoxifen
daily. Groups III and IV received in addition to TMX, 10 mg daily of medroxyprogesterone
acetate (MPA) or progesterone respectively.
 "Calculated on the basis of colony norms for one exposure only (see Table 2).
no fetal remnants were recovered in the break-through bleeding of any of the 4 monkeys (this is
normally to be expected if abortion occurs after Day 50), it was felt that establishment of pregnancy
was prevented in these monkeys by tamoxifen treatment, as it was in those of Group II, but
menstruation was delayed because of the effect of MPA.
In the progesterone-treated animals (Group IV), 2 out of 11 monkeys continued pregnancy to
term. Of the remaining 9, one showed an early end of the cycle (Day 24) and the others showed
vaginal bleeding between Days 36 and 48. Five of these monkeys were CG-positive on Day 28. The
remaining 3, which were CG-negative, also showed delay in bleeding and this could be due to
continuous administration of progesterone.
Effect of tamoxifen on serum oestrogen andprogesterone profiles
The serum oestrogen concentration of mated monkeys treated with tamoxifen alone (Group II,
Fig. 2) was significantly higher than that of the control (Group I, Fig. 2) pregnant monkeys
(P < 001). Treatment with progesterone, however, significantly reduced serum oestrogen concen¬
tration (Group IV, Fig. 2;  < 0-01). Treatment with MPA also resulted in reduction in serum
oestrogen values but this effect was much less than that produced by progesterone (compare
Groups III & IV, Fig. 2).
The serum progesterone concentrations of the tamoxifen-treated mated monkeys were not
significantly different from those of the control pregnant monkeys (Groups I & II, Fig. 2). Progest¬
erone values measured after MPA treatment were not markedly different from those recorded after
tamoxifen treatment alone (compare Groups II & III, Fig. 2), except for Day 28 and beyond. It is
not clear whether this reduction in progesterone values on Day 28 and beyond (P < 005) is a
reflection of the antagonistic effect of MPA on the luteotrophic activity of tamoxifen (MPA does
not cross-react in the progesterone radioimmunoassay). As expected, serum concentrations of pro¬
gesterone were markedly increased after treatment with exogenous progesterone (Groups II & IV,
Fig. 2).
Effect of changing tamoxifen dose and schedule ofadministration on pregnancy establishment
Proven fertile monkeys were mated between Days 9 and 14 of the cycle and divided into 4
groups. The control group (I) did not receive any treatment, but monkeys in Groups II, III and IV
received tamoxifen at 2-5, 150 and 7-5mg/day respectively. Monkeys in Groups III and IV
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Fig. 2. Oestradiol and progesterone concentrations (mean + s.d.) during the luteal phase of the
menstrual cycle in mated female bonnet monkeys fed with tamoxifen. Group I, controls: preg¬
nant (O—O) (N = 4); non-pregnant (·—·) (N = 2); Group II, tamoxifen, 15 mg daily from
Days 18 to 30 (N = 9); Group III, tamoxifen, 15 mg daily from Days 18 to 30 and MPA, 10 mg
daily from Days 18 to 30 (N = 4); Group IV, tamoxifen, 15 mg daily from Days 18 to 30 and
progesterone, 10 mg daily from Days 18 to 30 (N = 9). In Groups II, III and IV, the steroid
profiles of only those animals in which pregnancy was blocked are shown.
received tamoxifen from Days 16 to 20 of the cycle, but those in Group II were treated from Days
18 to 30 of the cycle. The control group of females showed a normal conception rate of 60% after
one ovulatory cycle exposure to males, but conception in the other groups was reduced (Table 4).
The hormone concentrations in these females are shown in Fig. 3.
The ability of tamoxifen to promote progesterone production when given at the daily dose of
15 mg for 13 days (Fig. 2) was abolished by reducing the daily dose to 2-5 mg (Fig. 3, Group II
and/or shortening the duration of treatment to 5 days (Fig. 3, Groups III & IV). The progesterone
profile beyond Day 24 of the cycle after 2-5 mg (13 days) or 7-5 mg (5 days) tamoxifen was signifi¬
cantly different from that observed when 15 mg tamoxifen were given for 13 days (P < 005). The
effect of tamoxifen on oestrogen production was also substantially diminished by reducing the dose
and/or duration of treatment (compare Fig. 3, Groups III & IV with Fig. 2, Group II;  < 005).
Effect of tamoxifen on post-treatment cycles
With the high dose of tamoxifen (15 mg for 13 days), the immediate post-treatment cycle was
usually extended from a mean (+ s.d.) of 28-0 + 4-3 to 46-4 + 20-2 days. The following cycle
Effect of altered tamoxifen regimen and schedule on pregnancy establishment in
bonnet monkeys
No. pregnant
Durationt %
Treatment* (days) No. mated No. expected! No. recorded protection
I
II
III
IV
Control
TMX (2-5 mg)
TMX (150 mg)
TMX (7-5 mg)
18-30
16-20
16-20
10
10
5
10
0
66
100
S4
*Number in parentheses indicates daily dose per monkey.
tRefers to days of cycle for which treatment was given.|Calculated on the basis of colony norms for one exposure only (see Table 2).
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Fig. 3. Progesterone and oestradiol concentrations (mean + s.d.) during the luteal phase of the
menstrual cycle in mated female bonnet monkeys fed with tamoxifen at different doses and
schedules. Group I, controls (N = 10); Group II, tamoxifen, 2-5 mg daily from Days 18 to 30(N = 10); Group III, tamoxifen, 7-5 mg daily from Days 16 to 20 (N = 10); Group IV, tamoxi¬
fen, 15 mg daily from Days 16 to 20 (N = 5). In Groups II, III and IV, the steroid profiles of
only those animals in which pregnancy was blocked are shown.
(treatment plus 2 cycles) was normal (with regard to length and hormonal profiles) and mating
during the 3rd or 4th post-treatment cycle resulted in most of the females becoming pregnant.
Reducing the dosage of tamoxifen exposure to 5 days only (15 mg daily from Days 16 to 20 only) or
lowering the daily dosage (2-5 mg daily for 13 days) had no effect on the cycle length of hormonal
profile of the post-treatment cycle and all the monkeys became pregnant after mating in subsequent
cycles.
Discussion
The functional significance of luteal-phase oestrogen in the primate, particularly that of the
pregnant cycle, remains unclear. Besides its own receptor concentration in the uterus, oestrogen is
known to regulate that of progesterone (Kreitmann et al, 1979). It is, however, unclear to what
extent progesterone receptor turnover is dependent upon oestrogen and whether this dependency is
influenced by preovulatory and luteal phase concentration. Sankaran et al (1984) administered
Zuclomiphene, an oestrogen antagonist (also known to have agonistic activity in the primate at
some doses), to female rhesus monkeys from Days 5 to 11 of the cycle, followed by mating between
Days 9 and 15 of the cycle. The dose used (2 mg/kg body weight) apparently did not block ovula¬
tion but prevented conception in 4 out of 5 monkeys. In a few other instances in which anti-
oestrogens have been tested in monkeys, the compounds have been given within 24 h of mating(Morris et al, 1967). As far as we are aware, except for one study with marmosets, tamoxifen has
not been tested for its antifertility effects in primates. In the marmoset study, 4 out of 6 females
treated with 0-2 mg tamoxifen/kg/day for 6 months remained non-pregnant for the duration of
treatment (Furr et al, 1979).
Ovulation occurs in the bonnet monkey by Day 11-12 of the cycle (N. Ravindranath & N. R.
Moudgal, unpublished observation). In a fertile cycle, fertilization occurs within 24 h of ovulation
and implantation by Day 19-21 (Enders & Hendrickx, 1980). By starting tamoxifen treatment 3-5
days after fertilization, we have minimized any oestrogenic effect it could be having on tubai trans¬
port. The results of the current study show that tamoxifen is effective in interfering with the estab¬
lishment of pregnancy even when its administration is started as late as Day 16 or 18 of the cycle.
The percentage protection against pregnancy conferred by tamoxifen ranged from 66% (2-5 mg/
day for 13 days) to 100% (15 mg/day for 5 days). The study shows that the efficacy of the drug(Table 4) is dependent not only on the dose and duration of administration but also on the time of
start of treatment (from Day 16 instead of Day 18). Statistical analysis of data pooled from
Tables 3 and 4 shows that tamoxifen is efficient at preventing conception (Table 5). Exogenous
progesterone treatment did not markedly vary the effect.
In the pregnant rhesus monkey the ratio of endometrial nuclear oestrone/oestradiol receptors
increases from 0-50 on Day 5 to 0-80 on Day 18 and to 2-45 on Day 24 of a fertile cycle (Kreitmann-
Gimbal et al, 1981). Assuming that the bonnet monkey also exhibits a uterine oestrogen receptor
pattern like that of the rhesus monkey, it was considered desirable to start tamoxifen treatment
from Day 16 of the cycle, well before the onset of the increase in nuclear oestrogen receptors. The
relatively long half-life of the drug (7-5 days; Fromson et al, 1973) also prompted us to reduce the
duration of exposure to 5 days only. Neither of these manipulations affected the overall efficacy of
the drug.
Tamoxifen could be promoting luteal function in the bonnet monkey by increasing basal
concentrations of LH or antagonizing any natural luteolytic activity oestrogen may exhibit (Karsch
et al, 1973). The luteal tissue is known to have oestrogen receptors although their role in regulating
progesterone production remains obscure. Tamoxifen-treated monkeys showed an increase or no
change in serum oestrogen concentrations. This increase could be due to tamoxifen affecting
catabolism of oestrogen by occupying its receptor sites in the liver. Progesterone treatment brought
about a marked suppression in serum oestrogen concentrations, but the mechanism by which this is
achieved is not known.
Table 5. Statistical analysis of data pooled from Tables 3 and 4 for
significance
Group Treatment No. mated
Pregnancies
recorded Contingency test*
I
II
III
Control
Tamoxifen
Tamoxifen +
progestagen
16
35
16
10
4
3
1:11,  < 0-01
I:III,  < 005
II:III, not-significant
For Groups II and III, irrespective of dosage and duration of treatment, data of all
monkeys given tamoxifen alone or tamoxifen + progestagen respectively have
been considered.
*According to the method of Mainland & Murray (1952).
The results of the present study are at variance with the conclusion of Meyer et al. (1969) that
progesterone alone can maintain early pregnancy in the primate. Although the reason for this is not
evident at present, it is possible that the experimental animal used has influenced the overall results
obtained. Ovariectomized monkeys, according to Bosu & Johansson (1975), still have basal values
of oestrogen (perhaps adrenal in origin) and these may be adequate to maintain the receptor load
once the preovulatory oestrogen induces receptors in the endometrium.
The mechanism by which tamoxifen is expressing its antifertility activity in primates is currently
unknown. By delaying the start of tamoxifen administration, any oestrogenic effect it may have on
tubai transport is circumvented and the present study also shows that it has no inhibitory effect on
ovarian steroid production. The possibility of the drug influencing the uterine microenvironment
making it hostile for implantation or for the blastocyst to survive has to be considered.
The present study (1) shows that there is a definitive need for oestrogen for pregnancy establish¬
ment in the primate and (2) demonstrates the efficacy of an antioestrogen such as tamoxifen to
serve as a post-ovulatory contraceptive. Although no direct data are available on changing patterns
of oestrogen receptors during the peri-implantation period of women, if women in early pregnancy
exhibit a pattern very similar to that of the rhesus monkey during Days 15-24 of the mated cycle,
administration of tamoxifen during the early secretory phase in women (Days 16-20) is likely to
antagonize the action of oestradiol during this critical phase. The attractiveness of tamoxifen as a
contraceptive lies in the fact that it is a specific antagonist of oestrogen and does not exhibit any
antiglucocorticoid activity. Furthermore, tamoxifen appears to be a safe drug and a considerable
body of information is available on its usage in women (Furr et al, 1979).
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